Stocks and Investing Stocks and Investing
Wed, March 8, 2023
[ 12:00 AM ] - WOPRAI
Gaurav Mehta Maintained (AFCG) at Strong Buy with Decreased Target to $21 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Aaron Hecht Maintained (AFCG) at Buy with Decreased Target to $17 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Harrison Vivas Maintained (AFCG) at Buy with Decreased Target to $21 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Merrill Ross Maintained (AFCG) at Hold with Decreased Target to $14 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Nicholas Jones Reiterated (ACVA) at Buy and Held Target at $14 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Jade Rahmani Downgraded (ACRE) to Hold and Held Target at $13 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Jaeson Schmidt Maintained (BKSY) at Strong Buy with Decreased Target to $32 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Daniel Ives Maintained (AAPL) at Buy with Increased Target to $190 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Ken Herbert Reiterated (ASLE) at Buy and Held Target at $21 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Mara Goldstein Maintained (AUTL) at Strong Buy with Decreased Target to $12 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Brian Gesuale Maintained (AVAV) at Buy with Increased Target to $105 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Irene Nattel Maintained (CASY) at Hold with Increased Target to $273 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Ben Bienvenu Reiterated (CASY) at Buy and Held Target at $280 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Jason Gerberry Downgraded (CARA) to Sell and Decreased Target to $6 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Kevin Dede Reiterated (AQB) at Strong Buy and Held Target at $90 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Praneeth Satish Maintained (ARIS) at Hold with Decreased Target to $13 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Samantha Hoh Maintained (ARIS) at Buy with Decreased Target to $20 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Dick Bove Downgraded (BAC) to Hold and Held Target at $35 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Michael Ng Initiated (AXON) at Strong Buy and Held Target at $263 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Julien Dumoulin-Smith Upgraded (AY) to Strong Buy and Held Target at $32 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Matthew Hedberg Maintained (BASE) at Buy with Increased Target to $20 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Sanjit Singh Maintained (BASE) at Hold with Increased Target to $19 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Howard Ma Reiterated (BASE) at Strong Buy and Held Target at $20 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Rob Oliver Maintained (BASE) at Buy with Increased Target to $20 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Brad Reback Maintained (BASE) at Strong Buy with Increased Target to $19 on, Mar 8th, 2023
[ 12:00 AM ] - WOPRAI
Paul Treiber Maintained (BB) at Hold with Decreased Target to $4.5 on, Mar 8th, 2023
Tue, March 7, 2023
[ 12:00 AM ] - WOPRAI
Gilberto Garcia Maintained (BBD) at Hold with Decreased Target to $3 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Gilberto Garcia Maintained (BBDO) at Hold with Decreased Target to $3 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Dane Leone Maintained (BBIO) at Buy with Increased Target to $29 on, Mar 7th, 2023
[ 12:00 AM ] - WOPRAI
Paul Choi Maintained (BBIO) at Strong Buy with Increased Target to $28 on, Mar 7th, 2023

Paul Choi Maintained (BBIO) at Strong Buy with Increased Target to $28 on, Mar 7th, 2023


Published on 2024-10-28 02:09:51 - WOPRAI, Paul Choi
  Print publication without navigation


Paul Choi of Goldman Sachs, Maintained "BridgeBio Pharma, Inc." (BBIO) at Strong Buy with Increased Target from $20 to $28 on, Mar 7th, 2023.

Paul has made no other calls on BBIO in the last 4 months.



There are 2 other peers that have a rating on BBIO. Out of the 2 peers that are also analyzing BBIO, 0 agree with Paul's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Paul

  • Tyler Van Buren of "Cowen & Co." Initiated at Buy on, Monday, February 6th, 2023
  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Decreased Target to $19 on, Monday, January 23rd, 2023
Contributing Sources